BRPI0419273A - composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais - Google Patents

composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais

Info

Publication number
BRPI0419273A
BRPI0419273A BRPI0419273-7A BRPI0419273A BRPI0419273A BR PI0419273 A BRPI0419273 A BR PI0419273A BR PI0419273 A BRPI0419273 A BR PI0419273A BR PI0419273 A BRPI0419273 A BR PI0419273A
Authority
BR
Brazil
Prior art keywords
cattle
methods
parasitic infections
animals
compositions
Prior art date
Application number
BRPI0419273-7A
Other languages
English (en)
Inventor
Dale E Shuster
David G Sawutz
Kanwal J Varma
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of BRPI0419273A publication Critical patent/BRPI0419273A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)

Abstract

COMPOSIçõES E MéTODOS PARA TRATAR INFECçõES MICROBIANAS E PARASìTICAS EM GADO VACUM E OUTROS ANIMAIS A presente invenção refere-se a novas formulações combinando um composto antiparasítico, tal como uma avermectina, com um antibiótico derivado de tianfenicol ou cloranfenicol fluorado tal como Florfenicol, são descritas. Os métodos para usar tais formulações no tratamento e prevenção de doenças infecciosas de bovinos e suínos, incluindo doença respiratória bovina e infecções parasíticas, são também descritos.
BRPI0419273-7A 2003-04-03 2004-04-01 composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais BRPI0419273A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46012603P 2003-04-03 2003-04-03
PCT/US2004/010143 WO2004089355A2 (en) 2003-04-03 2004-04-01 Compositions for treating microbial and parasitic infections in cattle and other animals

Publications (1)

Publication Number Publication Date
BRPI0419273A true BRPI0419273A (pt) 2008-07-15

Family

ID=33159732

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0419273-7A BRPI0419273A (pt) 2003-04-03 2004-04-01 composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais

Country Status (22)

Country Link
US (1) US20040198704A1 (pt)
EP (1) EP1608356A2 (pt)
JP (1) JP2006522147A (pt)
KR (1) KR20060021821A (pt)
CN (1) CN1767822A (pt)
AR (1) AR043824A1 (pt)
AU (1) AU2004227997A1 (pt)
BR (1) BRPI0419273A (pt)
CA (1) CA2519380A1 (pt)
CL (1) CL2004000710A1 (pt)
EC (1) ECSP056074A (pt)
HK (1) HK1080366A1 (pt)
MX (1) MXPA05010693A (pt)
NO (1) NO20055144L (pt)
NZ (1) NZ542379A (pt)
PE (1) PE20050099A1 (pt)
PL (1) PL378820A1 (pt)
RU (1) RU2359667C2 (pt)
TW (1) TW200503682A (pt)
UA (1) UA82359C2 (pt)
WO (1) WO2004089355A2 (pt)
ZA (1) ZA200507857B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050386A1 (es) 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
ES2452594T3 (es) * 2005-02-24 2014-04-02 Syngenta Participations Ag Formulación plaguicida en cápsulas
WO2008076256A1 (en) 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
BRPI0819849B8 (pt) * 2007-11-26 2021-05-25 Merial Ltd sistemas de solvente para formulações pour on para combater parasitas
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
WO2010014566A2 (en) 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
RU2397753C1 (ru) * 2009-05-12 2010-08-27 Общество с ограниченной ответственностью "Алвис" Композиция для лечения бактериальных инфекций у животных
KR101473979B1 (ko) * 2013-01-18 2014-12-26 한국썸벧(주) 마보플록사신을 포함하는 약제학적 조성물
RU2641962C2 (ru) * 2013-07-03 2018-01-23 С.П. Ветеринариа, С.А. Инъецируемая ветеринарная композиция
EP3023092A1 (en) * 2014-11-20 2016-05-25 Ceva Sante Animale Eprinomectin parenteral compositions
RU2649809C2 (ru) * 2015-03-03 2018-04-04 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN105079000B (zh) * 2015-09-22 2018-07-06 佛山市南海东方澳龙制药有限公司 一种组合物及其应用、制剂
CN105796488A (zh) * 2016-03-23 2016-07-27 张先碧 一种氟苯尼考溶液制剂及其制备方法
US9943387B2 (en) 2016-06-29 2018-04-17 International Business Machines Corporation Unmanned aerial vehicle-based system for livestock parasite amelioration
JP7082445B2 (ja) * 2016-12-23 2022-06-08 インターベット インターナショナル ベー． フェー． ウシ又はブタの呼吸器疾患を治療するための化合物
KR102647267B1 (ko) * 2021-06-29 2024-03-18 대한뉴팜(주) 툴라스로마이신과 톨페남산의 복합 주사제 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CA2445306C (en) * 2001-04-27 2008-02-12 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol

Also Published As

Publication number Publication date
WO2004089355A2 (en) 2004-10-21
ECSP056074A (es) 2006-03-01
HK1080366A1 (zh) 2006-04-28
CN1767822A (zh) 2006-05-03
WO2004089355A3 (en) 2005-01-20
CL2004000710A1 (es) 2005-05-27
PL378820A1 (pl) 2006-05-29
WO2004089355A8 (en) 2005-11-03
KR20060021821A (ko) 2006-03-08
CA2519380A1 (en) 2004-10-21
MXPA05010693A (es) 2005-12-12
TW200503682A (en) 2005-02-01
NO20055144L (no) 2005-11-02
US20040198704A1 (en) 2004-10-07
AR043824A1 (es) 2005-08-17
RU2005133875A (ru) 2006-03-20
AU2004227997A1 (en) 2004-10-21
JP2006522147A (ja) 2006-09-28
RU2359667C2 (ru) 2009-06-27
PE20050099A1 (es) 2005-02-28
ZA200507857B (en) 2007-04-25
EP1608356A2 (en) 2005-12-28
UA82359C2 (uk) 2008-04-10
NZ542379A (en) 2009-01-31

Similar Documents

Publication Publication Date Title
BRPI0410795A (pt) composições para tratamento de infecção em bovinos e suìnos
BR0311126A (pt) Composições e método para tratar infecção em gado bovino e em suìnos
TW200503682A (en) Compositions and method for treating microbial and parasitic infections in cattle and other animals
BRPI0408236A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
TW200626608A (en) Macrolides
UY30762A1 (es) Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol
TR200400363T4 (tr) Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
BRPI0905687A8 (pt) composto da fórmula i ou i&#39;, composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto
CR7195A (es) Nuevos derivados de oxazolidinonas como antibacterianos
CY1107480T1 (el) Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
BRPI0413528A (pt) isotiazol quinolonas e compostos afins como agentes antiinfecciosos
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
BR112012019565A2 (pt) formulações antimicrobianas com base em polissacarídeo
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
BRPI0407368A (pt) tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
BR0210401A (pt) Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano
BRPI0407271A (pt) Composição anti-helmìntica
GT200400022A (es) Nuevas composiciones antihelminticas e insecticidas
BR0210407A (pt) Composto, composição farmacêutica, uso de um composto e método de tratamento de um distúrbio ou de uma doença de corpo animal vivo, incluindo um humano
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания
BRPI0414454A (pt) agentes antibacterianos
BRPI0607473A2 (pt) infecção por helicobacter em suìnos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.